Cargando…

Effect of Pravastatin, a Potent 3‐Hydroxy‐3‐methylgliitaryl‐coenzyme A Reductase Inhibitor, on Survival of AH130 Hepatoma‐bearing Rats

3‐Hydroxy‐3‐methylglutaryl‐coenzyme A (HMG‐CoA) reductase inhibitor is known to have an inhibitory effect on cell growth in addition to a cholesterol‐lowering effect. This study examined the effect of pravastatin, a potent inhibitor of HMG‐CoA reductase, on the survival of AH130 hepatoma‐bearing rat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawata, Sumio, Kakimoto, Hiroki, Ishiguro, Hiroshi, Yamasaki, Eiji, Inui, Yoshiaki, Matsuzawa, Yuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1992
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918712/ https://www.ncbi.nlm.nih.gov/pubmed/1483925 http://dx.doi.org/10.1111/j.1349-7006.1992.tb02732.x

Ejemplares similares

Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2).
por: Kawata, S., et al.
Publicado: (1994)

Modulation of c‐myc Expression by Transforming Growth Factor β1 in Human Hepatoma Cell Lines
por: Ito, Nobuyuki, et al.
Publicado: (1990)

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
por: Kawata, S, et al.
Publicado: (2001)

Suppression of Human Pancreatic Cancer Growth in BALB/c Nude Mice by Manumycin, a Farnesyl:protein Transferase Inhibitor
por: Ito, Toshio, et al.
Publicado: (1996)

Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130).
por: Dessí, S., et al.
Publicado: (1992)

Chemoprevention by Pravastatin, a 3‐Hydroxy‐3‐methylglutaryl‐coenzyme A Reductase Inhibitor, of N‐Methyl‐N‐nitrosourea‐induced Colon Carcinogenesis in F344 Rats
por: Narisawa, Tomio, et al.
Publicado: (1996)

Elevated Levels of Plasma Transforming Growth Factor‐β in Patients with Hepatocellular Carcinoma
por: Shirai, Yasuhiro, et al.
Publicado: (1992)

The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases
por: Friesen, Jon A, et al.
Publicado: (2004)

Hypercholesterolemia and 3-Hydroxy 3-Methylglutaryl Coenzyme A Reductase Regulation during Ageing
por: Trapani, Laura, et al.
Publicado: (2009)

Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).
por: Dessì, S., et al.
Publicado: (1995)

Analysis of Autoantibodies to 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Using Different Technologies
por: Musset, Lucile, et al.
Publicado: (2014)

Varicose Remodeling of Veins Is Suppressed by 3‐Hydroxy‐3‐Methylglutaryl Coenzyme A Reductase Inhibitors
por: Eschrich, Johannes, et al.
Publicado: (2016)

In vitro Invasion of Endothelial Cell Monolayer by Rat Ascites Hepatoma Cells
por: Ohigashi, Hiroaki, et al.
Publicado: (1989)

Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies
por: Liang, Wen-Chen, et al.
Publicado: (2017)

Statin-Induced Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (Anti-HMGCR) Myopathy
por: Ghazal, Fatima, et al.
Publicado: (2023)

Coenzyme Q10 or Creatine Counteract Pravastatin-Induced Liver Redox Changes in Hypercholesterolemic Mice
por: Marques, Ana C., et al.
Publicado: (2018)

Sterol-induced dislocation of 3-hydroxy-3-methylglutaryl coenzyme A reductase from membranes of permeabilized cells
por: Elsabrouty, Rania, et al.
Publicado: (2013)

Potentiation of Invasive Capacity of Rat Ascites Hepatoma Cells by Transforming Growth Factor‐β
por: Mukai, Mutsuko, et al.
Publicado: (1989)

Expression of Transforming Growth Factor‐β1 mRNA in Human Hepatocellular Carcinoma
por: Ito, Nobuyuki, et al.
Publicado: (1990)

Establishment by Adriamycin Exposure of Multidrug‐resistant Rat Ascites Hepatoma AH130 Cells Showing Low DT‐diaphorase Activity and High Cross Resistance to Mitomycins
por: Wakusawa, Shinya, et al.
Publicado: (1997)

Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation
por: Tsushima, Takafumi, et al.
Publicado: (2022)

Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer()
por: Wei, Tzu-Tang, et al.
Publicado: (2016)

Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
por: Sasidhar, Manda V., et al.
Publicado: (2017)

Association of Common and Rare Genetic Variation in the 3‐Hydroxy‐3‐Methylglutaryl Coenzyme A Reductase Gene and Cataract Risk
por: Ghouse, Jonas, et al.
Publicado: (2022)

Case report: Diagnostic clues for anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy in pediatric patients
por: Watanuki, Keisuke, et al.
Publicado: (2023)

Abnormal Copper Accumulation in Non‐cancerous and Cancerous Liver Tissues of LEC Rats Developing Hereditary Hepatitis and Spontaneous Hepatoma
por: Li, Yu, et al.
Publicado: (1991)

Differing Distribution of Hepatocyte Growth Factor‐positive Cells in the Liver of LEC Rats with Acute Hepatitis, Chronic Hepatitis and Hepatoma
por: Nakayama, Nobuaki, et al.
Publicado: (1995)

The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells
por: Glynn, Sharon A, et al.
Publicado: (2008)

Species-Specific Expansion and Molecular Evolution of the 3-hydroxy-3-methylglutaryl Coenzyme A Reductase (HMGR) Gene Family in Plants
por: Li, Wei, et al.
Publicado: (2014)

Overexpressing 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (HMGR) in the Lactococcal Mevalonate Pathway for Heterologous Plant Sesquiterpene Production
por: Song, Adelene Ai-Lian, et al.
Publicado: (2012)

Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies
por: Ge, Yongpeng, et al.
Publicado: (2015)

Statins and Myotoxic Effects Associated With Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies: An Observational Study in Japan
por: Watanabe, Yurika, et al.
Publicado: (2015)

Genome-Wide Identification and Comparative Analysis of the 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase (HMGR) Gene Family in Gossypium
por: Liu, Wei, et al.
Publicado: (2018)

Genome Sequence of the Fungal Strain 14919 Producing 3-Hydroxy-3-Methylglutaryl–Coenzyme A Reductase Inhibitor FR901512
por: Itoh, Hiroya, et al.
Publicado: (2017)

Juvenile idiopathic inflammatory myopathies with anti‐3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase antibodies in a Chinese cohort
por: Hou, Ying, et al.
Publicado: (2021)

Statin-naïve anti–3-hydroxy-3-methylglutaryl coenzyme A reductase antibody-positive necrotizing myopathy with heliotropic pseudoangioedema
por: Ortiz, Camila, et al.
Publicado: (2022)

3-Hydroxy-3-methylglutaryl coenzyme A reductase genes from Glycine max regulate plant growth and isoprenoid biosynthesis
por: Wang, Shuai, et al.
Publicado: (2023)

An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer
por: Fort, Rafael Sebastián, et al.
Publicado: (2018)

Pravastatin Chronic Treatment Sensitizes Hypercholesterolemic Mice Muscle to Mitochondrial Permeability Transition: Protection by Creatine or Coenzyme Q(10)
por: Busanello, Estela N. B., et al.
Publicado: (2017)

Effect of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitor on Disease Activity in Patients With Rheumatoid Arthritis: A Meta-Analysis
por: Xing, Bin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0k5o9v1ghfgi3flrpkfkoj43jm